QMAP: a benchmark for standardized evaluation of antimicrobial peptide MIC and hemolytic activity regression

A Anthony Lavertu J Jacques Corbeil (Infection and Immunity Unit, Big Data Research Center, University Hospital Center of Quebec–Laval University) P Pascal Germain

Abstract

Abstract Antimicrobial peptides (AMPs) are promising alternatives to conventional antibiotics, but progress in computational AMP discovery has been difficult to quantify due to inconsistent datasets and evaluation protocols. We introduce QMAP, a domain-specific benchmark for predicting AMP antimicrobial potency (MIC) and hemolytic toxicity (HC50) with homology-aware, predefined test sets. QMAP enforces strict sequence homology constraints between training and test data, ensuring that model performance reflects true generalization rather than overfitting. Applying QMAP, we reassess existing MIC models and establish baselines for MIC and HC50 regression. Results suggest limited progress over six years, poor performance for high-potency MIC regression, and low predictability for hemolytic activity, emphasizing the need for standardized evaluation and improved modeling approaches for highly potent peptides. We release a Python package facilitating practical adoption, and with a Rust-accelerated engine enabling efficient data manipulation, installable with .

Article Details

Volume / Issue Vol. 1, Issue 1
Published June 03, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (3)

A

Anthony Lavertu

J

Jacques Corbeil

Infection and Immunity Unit, Big Data Research Center, University Hospital Center of Quebec–Laval University

P

Pascal Germain